Performing Department
(N/A)
Non Technical Summary
Probiotics are living microorganisms that confer beneficial effects on health beyond inherent basic nutrition when consumed in adequate quantities. Probiotic microorganisms consist mostly of strains from the genera Lactobacillus and Bifidobacterium, but strains of Bacillus, Pediococcus, and some yeasts have also been found as suitable candidates. Probiotic microorganisms can protect the host organism against harmful pathogens and strengthen the host's immune system. Probiotics can be found in dairy and non-dairy products. In recent years, probiotics have gained wide interest because of their generally accepted benefits. Freeze-drying is a commonly used technique for the production of dried powders of probiotics. Freeze-drying would cause limited shrinkage and maintain porous structures, which is ideal for rehydration potential with the max activity of microbes. Cells are first frozen to below the critical temperature of the formulation and then dried by sublimation under high vacuum in two phases: primary drying, during which unbound water is removed, and secondary drying, during which the bound water is removed. However, during freezing, the microorganism suspensions are exposed to high levels of stress such as low temperature (usually, -40 ~ -80°C) and ice crystal formation that ruptures and compresses cells, resulting in reduced viability and functionality. A common way of improving cell survivability is the addition of cryoprotectants such as skim milk powder, whey protein, trehalose, glycerol, and polymers. The drawback is that the concentration of the cryoprotectants and their protective effects can vary depending on the type of the microbial species, and the precise mechanisms remain unclear. Jun Innovations has developed a proprietary supercooling technology using the combined treatment of pulsed electric and oscillating magnetic fields that preserves perishable materials at below-freezing temperatures without the formation of ice crystals. Water is a typical diamagnetic material, indicating that the orbital motion of electrons is changed when an external magnetic field is applied, and a magnetic moment is induced in the opposite direction of the applied magnetic field. Furthermore, electric field rotates and vibrates water molecules in response to the field due to the intrinsic electric dipole moment and polarity of the molecules. The perpendicularly oriented electric and magnetic fields will effectively prevent the aggregation of water molecules in a freezing environment, allowing for the controlled ice nucleation process. By implementing the controlled supercooling phenomenon (-10 degC or below) prior to freeze-drying, it is anticipated to inhibit ice nucleation, and hence achieve a high degree of supercooling, leading to the formation of smaller and finer ice crystals in the end products, which would significantly increase the viability of probiotic bacteria armored with cold stress adaptation to survive during manufacturing as well as storage.
Animal Health Component
40%
Research Effort Categories
Basic
20%
Applied
40%
Developmental
40%
Goals / Objectives
Freeze-drying is the state of the art in drying for the preparation of such susceptible probiotics with minimum losses in quality. However, the freezing process can lead to cell damages due to ice crystal formation, resulting in a reduction in the viability and physiological functionality of probiotics. In temperature drops from 37 to -80 degC with slow drop rates, there was a considerable loss of cell viability with average survival rates of 75% in commercial facilities. The addition of cryoprotectants could significantly reduce drying damage and improved storage stability. However, the protective mechanisms are complex and are not fully understood. In order to ensure the viability and uniform quality of freeze-dried probiotic products, special attention needs to be paid to supercooling as a pretreatment process. This project is aimed to develop a novel supercooling module to inhibit ice nucleation in conjunction with freeze-drying to enhance bacterial viability and shelf life of dried probiotics.Objective 1: Design and optimize a freezing unit integrated with the supercooling function for proof-of-conceptObjective 2: Test and validate the unit for enhanced viabilities of Lactobacillus acidophilus during freeze-drying and storageObjective 3: Characterize freeze-dried Lactobacillus acidophilus and test for bacterial survival following simulated in vitro digestion
Project Methods
Task 1. Design and optimize a freezing unit integrated with the supercooling function The first task will be to design, fabricate, and optimize our current supercooling system for probiotics applications. The developed supercooling chamber has a 15 L volume (220 × 220 × 310 mm3) and it will be modified and optimized to fit the requirements for probiotic bacteria suspension preservation. The control unit is fully operational with the ability to control and monitor the PEF/OMF system, as well as the chamber temperature control through the PID algorithm. The developed supercooling unit will be placed in the existing freezer and self-programmed for the improved supercooling degree, which will lead to the increment of ice crystal nuclei and less damage to the cell membrane structure. Lactobacillus acidophilus will be used as a representative probiotic strain, and the combined PEF and OMF will be applied to the bacteria suspension to achieve an extended supercooling at -10°C prior to freezing at -40°C for freeze-drying. FDA suggested a dose of the magnetic field is limited to 2,000 mT for food applications, whereas our OMF strength will be below 50 mT. PEF will be applied using a pair of titanium electrodes (medical grade) in direct contact with the sample. The strength of the PEF will range below 1 V/cm, which would require 10 V and 50 mA at the most. For the successful implementation of OMF and PEF, a finite element method software (COMSOL Multiphysics, ver. 5.5) will be used to help visualize and optimize the field intensity and distribution since uniformly distributed electric and magnetic fields across the entire supercooling chamber will be critical to ensure creating and maintaining the supercooled state within biological samples. Frozen Lactobacillus acidophilus suspensions will be lyophilized using a freeze-dryer (VirTis VirTual 50L XL, SP Scientific, Gardiner, NY, USA).Task 2. Test and validate the unit for enhanced viabilities of freeze-dried probiotic bacteria Lactobacillus acidophilus provided by the Food Microbiology Laboratory (University of Hawaii at Manoa, Honolulu, HI) will be cultured in De Man, Rogosa, and Sharpe (MRS) broth (Difco Laboratories, Sparks, MD, USA) at 35°C for 16 hrs (initial count= ~109 CFU/mL) and harvested by centrifugation at 10,000 rpm for 10 min. The precipitated cells will be re-suspended in PBS (phosphate buffered saline) with bacterial cryoprotectants such as skim milk powder, trehalose, and sodium ascorbate. The effect of various cryoprotectants on the survival rate of probiotic bacteria during freeze-drying will be explored and optimized in connection with the supercooling protocols. The bacteria suspensions will be (1) immediately frozen at -40°C for a control group and (2) supercooled at -10°C for at least 12 hrs as a pretreatment process and then frozen at -40°C. The frozen bacteria suspensions will be freeze-dried for 24 or 48 hrs depending on sample volume and concentration of cryoprotectants. The freeze-dried powder will be kept in a polyethylene tube and stored in a shelf life testing equipment (40°C). The freeze-dried samples will be periodically assayed for cell viabilities (1, 4, 7, 14, 21, and 28 days) to investigate the long-term thermal stability of the product. The powder samples will be rehydrated in sterile PBS, appropriately diluted, and cultured on MRS agar, and incubated at 35°C for 48 hrs. The bacteria colonies will be counted, and the cell viability will be estimated.Alternatively, the efficacy of our developed supercooling technology in freeze-drying of Bifidobacterium spp., one of the most abundant genera in the gut of healthy adults, will be evaluated based on our collaborative partnership with Bifido Co, Ltd. The plan included that our supercooling module can be duplicated, shipped to Bifido Co., and tested for cell viabilities (i.e. Bifidobacterium animalis subsp. lactis strains BB-12, Bl-04, and AD011, Bifidobacterium bifidum BGN4, and Bifidobacterium longum BORI) in their manufacturing facilities, permitting strict anaerobic microbial work.Task 3. Characterize freeze-dried probiotic powders and test for bacterial survival following simulated in vitro digestion Properties of freeze-dried control powders pre-treated with conventional freezing (-40°C) will be compared against those that were supercooled (-10°C). Moisture content will be determined gravimetrically via oven drying until constant weight, as described by AOAC. Water activity, a factor that is known to significantly affect probiotic survival during storage, will be measured with an Aqualab Water Activity Meter (Aqualab Series 3, Pullman, WA) after equilibration with ultrapure water. Water solubility will be determined by dissolving 1 g of each powder into 25 mL of ultrapure water. Dissolved solutions will then be centrifuged at 760 x g for 10 min. The supernatant will be collected and dried overnight. Water solubility, bulk density, and flowability (Carr's Index and Hausner ratio) of each powder will be estimated. The morphology of the freeze-dried powders will be examined using the scanning electron microscopy (SEM). Briefly, powders will be mounted on a double side carbon tape on a stud and then coated with gold, prior to SEM examination with a Hitachi S-48000 field emission scanning electron microscope (University of Hawaii Biological Electron Microscope Facility).Freeze-dried control powders, supercool-treated powders, and a non-powdered bacteria solution control will be subjected to a 3-step simulated in vitro gastrointestinal model. Briefly, each sample will be combined with an oral phase base solution containing α-amylase, flushed with nitrogen, and incubated in a shaking water bath for 10 minutes at 37°C. The gastric phase will be simulated by adding pepsin and adjusting the pH to 2.5 with 1 M hydrochloric acid prior to incubation at 37°C for 1 h. The intestinal phase will be simulated by adding pancreatin, lipase, and bile extract and adjusting the pH to 6.5 with 1 M sodium bicarbonate. Following each stage (oral, gastric, and intestinal), bacterial colonies from digested samples will be enumerated as described in Task 2.